It is the first test the FDA has cleared for use in symptomatic adults aged 40 and over, according to C2N Diagnostics.

A new Alzheimer’s polygenic risk score combines genetic information from multiple ancestry groups and predicts disease more ...

According to the findings, these changes occurred at least seven years before amyloid plaques became visible on scans. The ...

New research points to certain immune cells in our lymph nodes that play a key role in causing the brain damage seen with ...

Will getting a blood test for amyloid levels eventually form part of routine primary care health checks, or are we putting ...

Answer: Research advances are helping scientists better understand Alzheimer’s disease, but no single study has found a cure ...

A 2019 study found evidence of a bacteria linked to gum disease and its toxic enzymes in the brains of people with ...

A protein thought to play a critical role in the progression of Alzheimer’s disease may not originate where scientists ...

Alzheimer’s disease is linked with changes in the brain, including shrinking of areas involved in memory and accumulation of ...

Penn Holderness hopes his mom's Alzheimer's fight can help end the disease forever Penn Holderness joins The Lead.

The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time ...